erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the https://oakley-sunglassesformen.us/Capestany-grandpa-of-Baumgartner-from-Janova-Lehota?Bryongran=233 january 2012  (21).